Subsequent development of diffuse large B-cell lymphomas and hodgkin lymphoma associated with primary immune disorder in a 6-year-old female: A case report and review of the literature

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 7, 2011, Pages

  Bautista Quach, Marnelli A ^a   Bedros, Antranik ^b   Wang, Jun ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

diffuse large B cell lymphoma; Epstein Barr virus; Hodgkin lymphoma; lymphoproliferative diseases; primary immune disorder

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; IFOSFAMIDE; IMMUNOGLOBULIN; MESNA; NAVELBINE; PREDNISOLONE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; VINCRISTINE SULFATE;

CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CHILD; DEATH; DRUG FEVER; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE ISCHEMIA; LARGE CELL LYMPHOMA; LEUKOPENIA; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOID CELL; PLASMA CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY;

CHILD; FEMALE; HODGKIN DISEASE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOMA, LARGE B-CELL, DIFFUSE;

EID: 80053315694     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318207a37a     Document Type: Review

References (26)

1. Elinatoba-Johnson KS, Jaffe ES. Lymphoproliferative disorders associated with congenital immunodeficiencies. Semin Diagn Pathol. 1997;14:35-47. (Pubitemid 27078884)
2. Fillipovich AH, Mathur A, Kamat D, et al. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res. 1992;52(19 suppl):5465s-5467s.
3. Leoncini L, Delsol G, Gascoyne RD. Aggressive B-cell lymphomas: a review based on the workshop of the XI meeting of the European Association for Haematopathology. Histopathology. 2005;46:241-255. (Pubitemid 40343171)
4. Canioni D, Jabado N, MacIntyre E, et al. Lymphoproliferative disorders in children with primary immunodeficiencies: immunological status may be more predictive of the outcome than other criteria. Histopathology. 2001;38:146-159. (Pubitemid 32193629)
5. Tinguely M, Vonlanthen R, Muller E, et al. Hodgkins diseaselike lymphoproliferative disorders in patients with different underlying immunodeficiency states. Mod Pathol. 1998;11: 307-312. (Pubitemid 28208090)
6. Knowles DM. Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol. 1999;12:200-217. (Pubitemid 29093902)
7. Strauss SE, Jaffe ES, Puck JM, et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline FAS mutations and defective lymphocyte apoptosis. Blood. 2001;98:194-200.
8. Peters AM, Kohfink B, Martin H, et al. Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkins disease. Exp Hematol. 1999; 27:868-874. (Pubitemid 29231025)
9. Donadieu J, Canioni D, Cuenod B, et al. A familial T-cell lymphoma with gamma; delta; phenotype and an original location. Possible role of chronic EBV infection. Cancer. 1996;77:1571-1577. (Pubitemid 26105396)
10. Van Krieken JH. Lymphoproliferative disease associated with immune deficiency in children. Am J Clin Pathol. 2004; 122(suppl):122s-127s.
11. Spina M, Vaccher E, Nasti G, et al. Human immunodeficiency virus-associated Hodgkins disease. Semin Oncol. 2000;27: 480-488. (Pubitemid 30626447)
12. Carbone A, Gloghini A. AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol. 2005; 130:662-670. (Pubitemid 43906640)
13. Huang JZ, Weisenburger DD, Vose JM, et al. Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska lymphoma study group. Leuk Lymphoma. 2004;45:1551-1557. (Pubitemid 38885997)
14. Al-Mansour M, Connors JM, Gascoyne RD, et al. Transformation to aggressive lymphoma in nodular lymphocytepredominant Hodgkins lymphoma. J Clin Oncol. 2010;28: 793-799.
15. Mao Z, Quintanilla-Martinez L, Raffeld M, et al. IgVH mutational status and clonality analysis of Richters transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Am J Surg Pathol. 2007;10:1605-1614. (Pubitemid 47482476)
16. Parrens M, Vergier B, Fitoussi O, et al. Sequential development of Hodgkins disease and CD30+ diffuse large B-cell lymphoma in a patient with MALT-type lymphoma: evidence of different clonal origin of single microdissected Reed- Sternberg cells. Am J Surg Pathol. 2002;26:1634-1642. (Pubitemid 35387227)
17. Oka K, Shinonaga M, Nagayama R, et al. Coexistence of primary pulmonary Hodgkin lymphoma and gastric MALT lymphoma associated with Epstein-Barr virus infection: a case report. Pathol Int. 2010;60:520-523.
18. Traverse-Glehen A, Pittaluga S, Gaulard P, et al. Mediastinal gray zone lymphoma: the missing link between classic Hodgkins lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol. 2005;29:1411-1421. (Pubitemid 41513290)
19. Murase T, Fujita A, Ueno H, et al. A case of age-related EBVassociated B-cell lymphoproliferative disorder metachronously showing two distinct morphologic appearances, one of a polymorphic disease resembling classical Hodgkin lymphoma, and the other of a large-cell lymphoma. Int J Hematol. 2009;89: 80-85.
20. Gheorghe G, Albano EA, Porter CC, et al. Posttransplant Hodgkin lymphoma preceded by polymorphic posttransplant lymphoproliferative disorder: report of a pediatric case and review of the literature. J Pediatr Hematol Oncol. 2007;29: 112-116. (Pubitemid 46213858)
21. Shimabukuro-Vornhagen A, Haverkamp H, Engert A, et al. Lymphocyte-rich classical Hodgkins lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkins study group trial. J Clin Oncol. 2005;23: 5739-5745.
22. Allemani C, Sant M, De Angelis R, et al. Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groups. Cancer. 2006;107:352-360. (Pubitemid 44036565)
23. Glaser SL, Clarke CA, Gulley ML, et al. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the greater San Francisco Bay Area, 1988-1998. Cancer. 2003;98:300-309. (Pubitemid 36828454)
24. Said JW. Immunodeficiency-related Hodgkin lymphoma and its mimics. Adv Anat Pathol. 2007;14:189-194. (Pubitemid 46659189)
25. Savage KJ, Monti S, Kutok JL, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood. 2003;102:3871-3879. (Pubitemid 37486965)
26. Samanta M, Takada K. Modulation of innate immunity system by Epstein-Barr virus-encoded non-coding RNA and oncogenesis. Cancer Sci. 2010;101:29-35.